✦ LIBER ✦

Labetalol, an alpha- and beta-adrenoceptor-blocking agent: its use in therapeutics. A summary of the symposium.

✍ Scribed by BN Prichard; DA Richards

Book ID: 117942131
Publisher: John Wiley and Sons
Year: 1979
Tongue: English
Weight: 897 KB
Volume: 8
Category: Article
ISSN: 0306-5251
DOI: 10.1111/j.1365-2125.1979.tb04788.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of an alpha- and beta-adrenocepto

Effect of an alpha- and beta-adrenoceptor-blocking agent (labetalol) on haemodynamics in hypertension.

✍ J Bahlmann; J Brod; W Hubrich; M Cachovan; P Pretschner 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB

Enzyme specificity and tissue distributi

Enzyme specificity and tissue distribution of zenarestat, an aldose reductase inhibitor, and its relevance in the use of zenarestat as a therapeutic agent against diabetic neuropathy

✍ Shoji Takakura; Hideaki Minoura; Yukinori Shimoshige; Kyoko Minoura; Ikuo Kawamu 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

## Abstract The enzyme specificity and tissue distribution of zenarestat, an aldose reductase inhibitor, was investigated in diabetic rats. Zenarestat inhibited both rat sciatic nerve aldose reductase (AR) activity and recombinant human AR with IC~50~ values of 7.5 and 44 nM, respectively. However,